identified the high expression of ten‐eleven translocation protein 1 (TET1) in sorafenib‐resistant HCC cells and silence of TET1 could significantly alleviate sorafenib resistance of HCC. This evidence concerns the gene TET1 and hepatocellular carcinoma.